NR1H4 and metabolic dysfunction-associated steatotic liver disease: This review of the scientific literature aims to describe the metabolism of bile acids and their “vital” cycle, and their role in lipogenesis and lipotoxicity in the liver and NAFLD, with a special focus on the role of the farnesoid X receptor in the pathogenesis and potential treatment of liver steatosis.